ENDONOVO THERAPEUTICS, INC. Current Liabilities
ENDONOVO THERAPEUTICS, INC. (ENDV) had Current Liabilities of $23.70 million as of 2023-09-30, per its 10-Q filed 2023-12-29.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2023-12-29
- 2023-09-30: Liabilities, Current $23.70M.
- 2023-06-30: Liabilities, Current $23.14M.
- 2023-03-31: Liabilities, Current $25.49M.
- 2022-12-31: Liabilities, Current $33.38M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2023-09-30 | $23.70M 10-Q · filed 2023-12-29 | |
| 2023-06-30 | $23.14M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $25.49M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $33.38M 10-Q · filed 2023-12-29 | |
| 2022-09-30 | $20.98M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | $20.68M 10-Q · filed 2022-08-22 | |
| 2022-03-31 | $19.77M 10-Q · filed 2022-05-19 | |
| 2021-12-31 | $17.70M 10-K · filed 2023-04-17 | |
| 2021-09-30 | $20.28M 10-Q · filed 2021-11-19 | |
| 2021-06-30 | $19.18M 10-Q · filed 2021-08-23 | |
| 2021-03-31 | $18.34M 10-Q · filed 2021-05-24 | |
| 2020-12-31 | $16.83M 10-K · filed 2022-04-14 | |
| 2020-09-30 | $15.34M 10-Q · filed 2020-11-19 | |
| 2020-06-30 | $14.92M 10-Q · filed 2020-08-19 | |
| 2020-03-31 | $14.05M 10-Q · filed 2020-06-12 | |
| 2019-12-31 | $23.62M 10-K · filed 2021-04-13 | |
| 2019-09-30 | $19.82M 10-Q · filed 2019-11-19 | |
| 2019-06-30 | $20.21M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $15.24M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $15.48M 10-K · filed 2020-05-04 | |
| 2018-09-30 | $17.47M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $12.32M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $12.27M 10-Q · filed 2018-05-18 | |
| 2017-12-31 | $13.41M 10-K · filed 2019-04-15 | |
| 2017-09-30 | $13.19M 10-Q/A · filed 2017-11-09 | |
| 2017-06-30 | $9.20M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $13.27M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $8.72M 10-K · filed 2018-04-06 | |
| 2016-09-30 | $8.29M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $6.96M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $9.00M 10-Q · filed 2016-05-27 | |
| 2015-12-31 | $9.49M 10-K · filed 2017-04-17 | $7.48M 10-K · filed 2016-04-05 |
| 2015-09-30 | $5.81M 10-Q · filed 2015-11-23 | |
| 2015-06-30 | $5.27M 10-Q · filed 2015-08-19 | |
| 2015-03-31 | $4.73M 10-Q · filed 2015-06-15 | |
| 2014-12-31 | $4.55M 10-K · filed 2016-05-17 | |
| 2013-12-31 | $4.01M 10-K · filed 2015-06-15 | |
| 2013-09-30 | $3.33M 10-Q · filed 2013-12-18 | |
| 2013-06-30 | $2.88M 10-Q/A · filed 2013-08-28 | |
| 2013-03-31 | $2.27M 10-Q/A · filed 2013-06-21 | |
| 2012-12-31 | $1.75M 10-Q · filed 2013-12-18 | |
| 2012-09-30 | $1.64M 10-Q · filed 2012-11-29 | |
| 2012-06-30 | $1.20M 10-Q · filed 2012-08-20 | |
| 2012-03-31 | $995.85K 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $690.80K 10-K/A · filed 2013-05-03 | $1.29K 10-K · filed 2012-04-13 |
| 2010-12-31 | $1.90K 10-K · filed 2012-04-13 |